I don't know why we focus on minutiae of details like reagents...

I don't know why we focus on minutiae of details like reagents and capacity of pilot. They dont have to tell you and probably never will.

Think outcomes guys...these are the things I think that matter at this stage are:
1. Are they working on met work, do they have it locked down? (Not yet its a 'work in progress')
2. Do we have a means of rapidly testing out met work (fail fast to develop a method)
3. Do we have samples to test to indicate coverage of target areas (yes)
4. Do we have the right set of experts and experience looking at this (?)
4. Can we fund this quarter (yes)
5. Where will funds come from for next quarter ( there are options, trial mining or CR) i suspect they are awaiting ema results before CR to reduce the number of new shares.

Later on, I would expect that we start to see economic outputs when a met process is locked down. Such as.... Is the approach economical or not, with costs per ounce.

I know we all like to geek out on reagents and stuff like that, but as investors, you need to put your business hats on and care about outcomes rather than double checking their work.

As an example of what youre doing, its like asking an airline the exact means by which they come to decide the routes they fly. They will never tell you. What they will is: Is the new route economical or not, what does it enable for the business, & how does it perform (in operation)

Thx, smite.